We recommend to make use of MedMira fundamental analysis to find out if markets are presently mispricing the entity. Strictly speaking this technique allows you to check out available financial ratios of MedMira as well as the relationship between them. We were able to interpolate twenty-six available fundamentals for MedMira, which can be compared to its peers in the industry. The stock experiences a very speculative upward sentiment. Check odds of MedMira to be traded at C$0.1045 in 90 days. Key indicators impacting MedMira's financial strength include:
Please note, the imprecision that can be found in MedMira's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of MedMira. Check MedMira's Beneish M Score to see the likelihood of MedMira's management manipulating its earnings.
MedMira Stock Summary
MedMira competes with Atrium Mortgage, Primaris Retail, HOME DEPOT, and HPQ Silicon. MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Latin America and the Caribbean, Europe, the Asia Pacific, and internationally. The company was founded in 1993 and is headquartered in Halifax, Canada. MEDMIRA INC operates under Biotechnology classification in Canada and is traded on TSX Venture Exchange.
Foreign Associate
USA
Specialization
Health Care, Pharmaceuticals, Biotechnology & Life Sciences
You should never invest in MedMira without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of MedMira Stock, because this is throwing your money away. Analyzing the key information contained in MedMira's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
MedMira Key Financial Ratios
There are many critical financial ratios that MedMira's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that MedMira reports annually and quarterly.
Comparative valuation techniques use various fundamental indicators to help in determining MedMira's current stock value. Our valuation model uses many indicators to compare MedMira value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MedMira competition to find correlations between indicators driving MedMira's intrinsic value. More Info.
MedMira is considered to be number one stock in return on asset category among its peers. It also is considered to be number one stock in operating margin category among its peers . At this time, MedMira's Operating Profit Margin is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MedMira's earnings, one of the primary drivers of an investment's value.
MedMira Systematic Risk
MedMira's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. MedMira volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on MedMira correlated with the market. If Beta is less than 0 MedMira generally moves in the opposite direction as compared to the market. If MedMira Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one MedMira is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of MedMira is generally in the same direction as the market. If Beta > 1 MedMira moves generally in the same direction as, but more than the movement of the benchmark.
MedMira Total Assets Over Time
Today, most investors in MedMira Stock are looking for potential investment opportunities by analyzing not only static indicators but also various MedMira's growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of MedMira growth as a starting point in their analysis.
Along with financial statement analysis, the daily predictive indicators of MedMira help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of MedMira. We use our internally-developed statistical techniques to arrive at the intrinsic value of MedMira based on widely used predictive technical indicators. In general, we focus on analyzing MedMira Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build MedMira's daily price indicators and compare them against related drivers.
When running MedMira's price analysis, check to measure MedMira's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedMira is operating at the current time. Most of MedMira's value examination focuses on studying past and present price action to predict the probability of MedMira's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedMira's price. Additionally, you may evaluate how the addition of MedMira to your portfolios can decrease your overall portfolio volatility.